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Secular Trends in Candidemia-Related
Hospitalization in the United States,
2000–2005
Marya D. Zilberberg, MD; Andrew F. Shorr, MD, MPH;
Marin H. Kollef, MD
In the United States, from January 1, 2000, through December 31,
2005, the incidence of candidemia-related hospitalization per
100,000 population rose by 52%, from 3.65 to 5.56 cases; and the
incidence per 1,000 hospitalizations rose by 49%, from 0.28 to 0.42
cases. The proportion of all candidemia-related hospitalizations in
which candidemia was the principal diagnosis remained stable at
approximately 14%.
Infect Control Hosp Epidemiol 2008; 29:978-980

Hospitals in the United States are experiencing unprecedented
growth in the incidence of infection due to antibiotic-resistant
organisms, such as methicillin-resistant Staphylococcus aureus
and Clostridium difficile. The common thread that ties many
of these infections is the host’s prior exposure to antibiotics.
Another group of pathogens for which infection is associated
with exposure to antibiotics is Candida species, common
causes of nosocomial bloodstream infections that have high
morbidity, mortality, and costs.1-3 Although studies examining
fungal bloodstream infection epidemiology in the 1980s noted
a near quintupling of Candida bloodstream infection rates
during that decade in the US hospitals,1 up-to-date population data that make it possible to understand the full burden
of candidemia in the United States are lacking. To fill this
gap, we sought to quantify current population trends in the
incidence of adult hospitalization with candidemia in the US
hospitals.

methods
We identified candidemia-related hospitalizations for 2000–
2005 from the Nationwide Inpatient Sample data, available
on the Healthcare Costs and Utilization Project Net Web site,
administered by the Agency for Healthcare Research and
Quality.4 Candidemia was identified by the presence of the
International Classification of Diseases, Ninth Revision, Clinical
Modification (ICD-9-CM) diagnosis code 112.5 (disseminated
candidiasis), and the numbers of discharges per year were
age-stratified. To benchmark candidemia incidence against
the general growth in hospitalizations over time, we obtained
age-stratified numbers of total hospitalizations from Healthcare Costs and Utilization Project Net for each year and derived the candidemia-related hospitalization incidence as a
function of total annual number of hospitalizations in the

United States. We also obtained censal and intercensal data
on the numbers and demographic characteristics of the US
population between 2000 and 2005 from the US Census Bureau, and we calculated age-specific population hospitalization incidence rates. Finally, we examined time trends for
candidemia as the principal diagnosis. The Nationwide Inpatient Sample definition of a principal diagnosis is “that
condition established after study to be chiefly responsible for
occasioning the admission of the patient to the hospital for
care. The principal diagnosis is always the reason for
admission.”4

results
The number of adult discharges from US hospitals with a
diagnosis of candidemia rose from 10,299 in 2000 to 16,500
in 2005, equating to a population incidence of 3.65 cases per
100,000 in 2000 to 5.56 cases per 100,000 in 2005 (Table).
We noted approximately an order of magnitude difference in
the candidemia-related hospitalization incidence between the
youngest group (1.42 cases per 100,000 population among
those aged 18–44 years) and the oldest group (17.29 cases
per 100,000 population among those aged at least 85 years)
in the year 2000, a relationship that persisted throughout the
study period (Table). Each group experienced a similar rise
in the incidence of candidemia-related hospitalizations from
January 1, 2000, through December 31, 2005: an increase of
41% among people aged 18–44 years, 50% among those aged
45–64 years, 49% among those aged 65–84 years, and 45%
among those aged at least 85 years.
An examination of the trends in the incidence of candidemia-related hospitalizations compared with the total annual number of hospitalizations in the United States yielded
similar results, although, for the oldest group, the rise in
hospitalization incidence was greater than the rise in the population incidence (51% increase vs 45% increase) (Table). In
the analysis of candidemia as the principal diagnosis, the
percentage of total candidemia-related hospitalizations in
which candidemia was the principal diagnosis remained stable
at approximately 14% during the study period (Figure). Although minor fluctuations in the proportion of total candidemia-related hospitalizations in which candidemia was the
principal diagnosis were noted for the 3 younger groups, the
fluctuations seen among the group aged at least 85 years were
more pronounced, ranging from 28.9% in 2001 to 15.4% in
2004 (Figure).

discussion
We have documented an approximately 50% increase in the
incidence of hospitalization with candidemia in US hospitals
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table. Annual Population Incidence and Hospitalization Incidence of Candidemia-Related Hospitalization, by Age Group, United States, 2000–2005
Incidence measure,
patient age group
No. of cases per 100,000 population
18–44 years
45–64 years
65–84 years
x85 years
No. of cases per 1,000 hospitalizations
18–44 years
45–64 years
65–84 years
x85 years

2000

2001

2002

2003

2004

2005

1.42
4.53
12.52
17.29

1.53
5.06
14.16
17.32

1.80
5.97
15.51
19.46

2.20
6.16
16.84
21.48

2.26
6.66
16.49
21.86

2.01
6.81
18.64
25.01

0.16
0.38
0.38
0.29

0.17
0.43
0.41
0.28

0.20
0.49
0.46
0.33

0.25
0.51
0.50
0.37

0.25
0.55
0.50
0.39

0.23
0.57
0.57
0.43

from January 1, 2000, through December 31, 2005. Consistently, the highest incidence was seen in the oldest group of
patients and the lowest incidence in the youngest. Although
the proportion of candidemia-related hospitalizations in
which candidemia was the primary diagnosis remained stable
overall, substantial fluctuations were noted for the oldest
group of patients.
Candida species are recognized as important causes of
bloodstream infections, particularly among critically ill and
immunocompromised patients.1 A recent systematic review
documented that the attributable mortality for candidemia
ranged from 5% to 71%,2 and survivors of this disease incur
substantial increases in the duration and the costs of hospitalization.3 Furthermore, although in 1990 nearly 80% of
isolates representing candidemia were Candida albicans, more

recently this percentage has decreased to less than 50%, raising the probability of resistance to azoles.5,6 Because of these
clinical and economic implications of bloodstream infection
due to Candida, it is critical to understand its epidemiologic
trends, and our data provide the needed generalizable information on the current state of the population incidence of
hospitalization with infection due to this evolving pathogen.
Several prior investigations reported trends in candidemiarelated hospitalizations over time both in the United States
and abroad. For example, Martin et al.,7 utilizing the ICD9-CM codes 117.9 (disseminated fungal infection), 112.5 (disseminated candidiasis), and 112.81 (candidal endocarditis),
documented a substantial rise in fungal sepsis incidence in
the United States between 1979 and 2001. Because this study
did not report specifically on candidemia, we are unable to

figure. The proportion of all candidemia-related hospitalizations in which candidemia is the principal diagnosis, by age group (in
years), 2000–2005.
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make direct comparisons with our results with regard to the
magnitude of change. Other studies from abroad have noted
increases in the incidence of hospitalization with candidemia
that were similar in magnitude to the increase in our study.8
Our analysis has multiple limitations. It relied on ICD-9CM coding to identify candidemia-related hospitalizations,
which may have predisposed our case ascertainment to misclassification. Although the accuracy of the coding for candidemia is unknown, giving credence to our numbers is the
report by Zaoutis et al.,9 who, in an approach similar to ours,
noted candidemia incidence to be 30 cases per 100,000 adults
hospitalized in the United States in 2000; in our analysis we
found 28.3 cases per 100,000 hospitalizations in the same
year. Additional support is provided by the relative stability
over time of the proportion of all candidemia-related hospitalizations in which candidemia was the principal diagnosis.
Nevertheless, the administrative nature of the data set is likely
to have resulted in an underestimate of the full burden of
candidemia.
The incidence of candidemia has risen by 50% in the time
period between 2000 and 2005, and age-adjusted estimates
confirm a rise among all adult age groups. Given the magnitude of attributable morbidity, mortality, and costs of this
disease, the implications of this increase are likely not trivial.
Our findings, in combination with reports of the increasing
incidence of recovery of azole-resistant isolates from patients
with candidemia, should compel a closer examination of this
emerging disease and its impact on patient and systemwide
outcomes.
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